Immunology · 1996 · 19 citations · 35 references
Life SciencesImmunologyMolecular BiologyCancer ImmunologyMolecular ImmunologyMolecular VirologyAntiviral ImmunityComplement SystemHuman Leukocyte Antigen SystemIge-mediated AllergyImmunoglobulin FunctionIge Receptor SignalingIge-mediated MechanismsImmunoglobulin E (Ige)Immunoglobulin ProductionLigand-receptor AffinityProtein-protein Interaction ModulesTransmembrane HelicesTransmembrane Proteins
Human CD21 has previously been described as a receptor for the C3d,g and iC3b proteins of complement, as a receptor for the gp350/220 envelope glycoprotein of the Epstein-Barr virus (EBV) and also as a receptor for inerferon-alpha (IFN-alpha). Structurally, CD21 consists of 15 to 16 short consensus repeats (SCR) of 60 to 75 amino acids followed by a transmembrane domain and an intracytoplasmic region. We reported that CD23, a low-affinity receptor for IgE (Fc epsilon R2), is a new functional ligand for CD21. We recently found that the sites of interaction of CD23 on CD21 are on SCR 5 to 8 and 1-2. The first site is a lectin-sugar type of interaction and the second site is a protein-protein interaction. We report here that amongst the other ligands for CD21 (EBV, C3d,g and IFN-alpha), only EBV is able to inhibit the binding of CD23 to CD21. Furthermore, even a peptide from gp350/220 of EBV known to bind to CD21 is able to decrease CD23 binding to CD21. Since CD23/CD21 pairing is important in the control of IgE production, we tested the effect of the EBV-derived peptide on immunoglobulin production from peripheral blood mononuclear cells and purified tonsillar B cells. Interestingly, the EBV-peptide inhibited IgE and IgG4 production induced by interleukin-4, in a dose-dependent manner. The same results were obtained using either peripheral blood mononuclear cells or purified tonsillar B cells. Another CD21 ligand, C3, did not affect binding of CD23 to CD21 nor the production of IgE and IgG4. This study indicates that blocking CD23 binding to CD21 SCR 2 on human B cells selectively modulates immunoglobulin production.
35
CD21 is a ligand for CD23 and regulates IgE production
Jean-Pierre Aubry, Sibylle Pochon, Pierre Graber et al. · Nature · 1992 · 478 citations
Characterization of a human B cell-specific antigen (B2) distinct from B1.
Lee M. Nadler, Philip Stashenko, Richard R. Hardy et al. · The Journal of Immunology · 1981 · 354 citations
Glen R. Nemerow, Carolyn Mold, V K Schwend et al. · Journal of Virology · 1987 · 350 citations · Full text